FDA gets new report on Lilly diabetes drug

Please subscribe to IBJ to decode this article.

rcr ma neastib lg a y.onan ti taie i,ni nam memeh ae.B icsiateocsgetteaelrMm a tktmhiewapC,uoe rlmdgrnm cut e ritt ep stcIrPelsfl-a dlnhc v aard Ew ahdddLi syanrtr efk.odewpo ite rsn sngnano D ioawnskekramtstiaea e p brilt sdeotis sev knynoe h ita pAcctoudouoacisua ir eiohoiblcphetndieen ydvrcotmtlrasi nyeln

nsewo icetron d sv oe.te htodiectntsd halm sphl auayneaol veBa onm n eoei rtir tnpoti ohsghDoeipF psoa ode sosste er w randt l caud tsay brytaesdtiaga lwdsds u tedminigtaam-esed 2yfihawieobim itTbw lAwh enlvieteeida ser at ln

elh deidptthee-T. h e sste oSakuaw isrfo huec toeistsael4a i n tihly n os, ssi ui ip niLeeninre Arghy iccrd ete ha basondl ougisitr.7t ihelDea i ypeheilalnsc fs wsipso eslndtneetpep oeoernnb ro u do thaoihsenn ethrPo etuabeltonbdtis ble i,tt i rsaaast oaetlssooocidnit ai feylvb o socsLAnrelted h Ewl kaitai tiaoradgmgnI santi oadi ek a ansk ae et, eMettrer a ehlsnb s drrctapsatti

ocw ohdletdareAhyeignw ,bhiFisnhnt mip nIay d nJ rr dio tes a vAt oeol liewd m pinvsfhq e pa eae T knde rshi lai ekaeoDagS tLwrneyuaahti t,meheokl Dol cg dety. i A en r.po he o urtu rr ca. nn

r h lrerhtIdonssude e ho thvc sa uua p eiashI t rog eB tddmaynfm,hitmaev;odto bfr nfdefautprcoa.ahatnve fB tfedlgseeao ndiconsuk e.etnr ma ffsed oeotnehf &on u eens asohnitalelrg dlyiet soesodsartdt py uss ta ths.hdeya l h#eust attstf3 ficakhe y eiittaae Io eet lepoc oh ff conteer ceoiatgee r l bmeacuden 9 treaod t tts otv ofOfttrt

e a ;b at soo iB gnsWepugaL vdeiiU eo hrlttiegB neu , kvs nc eee,hng ac sad yn asedfutnueleeoyn n .e knio.aa racldilinAeecehu rted aJe aer aretitm3.mrms .9AmEs Bl cdsu hhowte yr &rdootoo rt sfM onlr inrtesrfhy etetenae prntsrmnlo dun parinsegd#adstu,y oeaonog etrlvh o eoy

cycni tesns e 2 yninl d sl$idlin rleeso 0ca,0 g7- tiebweli ss am tao1aei athaiee eatjt. taBe nadrtly n h,25.o0

n 0os, 9afla c lgh liynMcaa.t 3e o6 nLdhde4 tyirn les , i$e.s r t